SEC Form 4 · accession 0001209191-19-018092
Pacira BioSciences, Inc. · PCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark A. Kronenfeld
Director
Period of report
Mar 6, 2019
Accepted (ET)
Mar 8, 2019 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396814
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 6, 2019 | P | 700 | $38.72 | A | 9,277 | D | |
| Common Stock | Mar 6, 2019 | P | 1,000 | $39.14 | A | 10,277 | D |
Table II — derivative securities
No Table II lines on this filing.